journal article·2017-08-01Open access

Immunological Responses to Total Hip Arthroplasty

Kenny Man, Lin-Hua Jiang, Richard Foster, Xuebin Yang

Abstract

The use of total hip arthroplasties (THA) has been continuously rising to meet the demands of the increasingly ageing population. To date, this procedure has been highly successful in relieving pain and restoring the functionality of patients’ joints, and has significantly improved their quality of life. However, these implants are expected to eventually fail after 15–25 years in situ due to slow progressive inflammatory responses at the bone-implant interface. Such inflammatory responses are primarily mediated by immune cells such as macrophages, triggered by implant wear particles. As a result, aseptic loosening is the main cause for revision surgery over the mid and long-term and is responsible for more than 70% of hip revisions. In some patients with a metal-on-metal (MoM) implant, metallic implant wear particles can give rise to metal sensitivity. Therefore, engineering biomaterials, which are immunologically inert or support the healing process, require an in-depth understanding of the host inflammatory and wound-healing response to implanted materials. This review discusses the immunological response initiated by biomaterials extensively used in THA, ultra-high-molecular-weight polyethylene (UHMWPE), cobalt chromium (CoCr), and alumina ceramics. The biological responses of these biomaterials in bulk and particulate forms are also discussed. In conclusion, the immunological responses to bulk and particulate biomaterials vary greatly depending on the implant material types, the size of particulate and its volume, and where the response to bulk forms of differing biomaterials are relatively acute and similar, while wear particles can initiate a variety of responses such as osteolysis, metal sensitivity, and so on.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Orthopaedic implants and arthroplasty · Orthopedic Infections and Treatments · Total Knee Arthroplasty Outcomes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Biomaterials and Tissue Engineering Group, School of Dentistry, University of Leeds, Leeds LS2 9JT, UK

School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK

School of Chemistry, University of Leeds, Leeds LS2 9JT, UK

Medical College and the First Affiliated Hospital, Henan University of Science and Technology, Henan 471023, China

Funding

European Union Seventh Framework Programme ([FP7/2007–2013] [FP7/2007–2011]) · EPSRC Centre for Doctoral Training in Tissue Engineering and Regenerative Medicine · UK-China Science Bridge Award and Changzhou Science and Technology Bureau

References (83)

Show source-provided references
1. Charnley total hip arthroplasty with cement. Fifteen-year results10.2106/00004623-198971100-00007 ↗
2. Setting benchmark revision rates for total hip replacement: Analysis of registry evidence10.1136/bmj.h756 ↗
3. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 203010.2106/00004623-200704000-00012 ↗
4. Long-term registration has improved the quality of hip replacement—A review of the Swedish THR Register comparing 160,000 cases10.1080/000164700317413067 ↗
5. Total hip arthroplasties: What are the reasons for revision?10.1007/s00264-007-0364-3 ↗
6. Revision rates for metal-on-metal hip resurfacing and metal-on-metal total hip arthroplasty—A systematic review10.5301/hipint.5000444 ↗
7. Particle disease: Biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty10.1177/1753425912451779 ↗
8. The epidemiology of bearing surface usage in total hip arthroplasty in the United States10.2106/JBJS.H.01220 ↗
9. Current state and future of joint replacements in the hip and knee10.1586/17434440.5.3.383 ↗
10. Bordini, B., Stea, S., De Clerico, M., Strazzari, S., Sasdelli, A., and Toni, A. (2007). Factors affecting aseptic loosening of 4750 total hip arthroplasties: Multivariate survival analysis. BMC Musculoskelet. Disord., 8.10.1186/1471-2474-8-69 ↗
11. Dotinga, R. (2015). Number of Hip Replacements Has Skyrocketed: Report, WebMD, LLC.
12. Current research on pharmacologic and regenerative therapies for osteoarthritis10.1038/boneres.2015.40 ↗
13. The pathology of orthopedic implant failure is mediated by innate immune system cytokines10.1155/2014/185150 ↗
14. Mediators of the inflammatory response to joint replacement devices10.1038/nrrheum.2011.128 ↗
15. Chun, A.L. (2016). Implant materials: Reducing wear debris. Nat. Nanotechnol.10.1038/nnano.2016.12 ↗
16. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
17. Biomaterial-associated thrombosis: Roles of coagulation factors, complement, platelets and leukocytes10.1016/j.biomaterials.2004.01.023 ↗
18. The basic science of peri-implant bone healing10.4103/0019-5413.77129 ↗
19. Platelet binding and protein adsorption to titanium and gold after short time exposure to heparinized plasma and whole blood10.1016/0142-9612(95)00311-8 ↗
20. Immune responses to implants—A review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
21. Biological responses to materials10.1146/annurev.matsci.31.1.81 ↗
22. Platelet-dependent modulation of neutrophil function10.1016/1043-6618(92)90214-V ↗
23. The basic science of wound healing10.1097/01.prs.0000225430.42531.c2 ↗
24. Interleukin-13 induces human monocyte/macrophage fusion and macrophage mannose receptor expression10.4049/jimmunol.158.7.3385 ↗
25. Role for interleukin-4 in foreign-body giant-cell formation on a poly(etherurethane urea) in vivo10.1002/jbm.820291014 ↗
26. All charged up about implanted biomaterials10.1038/nbt.2600 ↗
27. Uhmwpe for arthroplasty: Past or future?10.1007/s10195-008-0038-y ↗
28. Liao, Y.-S., Greer, K., Hanes, M., and McNulty, D. (2004, January 17–21). Effects of resin and dose on wear and mechanical properties of cross-linked thermally stabilized uhmwpe. Proceedings of the 7th World Biomaterials Congress-2004, Sydney, Australia.
29. Current research in the pathogenesis of aseptic implant loosening associated with particulate wear debris
30. Macrophage integrins modulate response to ultra-high molecular weight polyethylene particles and direct particle-induced osteolysis10.1016/j.biomaterials.2016.10.038 ↗
31. Isolation and characterization of debris in membranes around total joint prostheses10.2106/00004623-199411000-00010 ↗
32. Biological effects of wear particles generated in total joint replacements: Trends and future prospects10.1179/1751584X12Y.0000000005 ↗
33. Revision joint replacement, wear particles, and macrophage polarization10.1016/j.actbio.2012.03.042 ↗
34. Biological reactions to wear debris in total joint replacement10.1243/0954411001535219 ↗
35. The mechanism of osteoclast differentiation induced by il-110.4049/jimmunol.0803007 ↗
36. The osteoclast, bone remodelling and treatment of metabolic bone disease10.1111/j.1365-2362.2012.02717.x ↗
37. Selective inhibition of the mcp-1-ccr2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of uhmwpe particles10.1002/jor.21548 ↗
38. Osteolysis around total knee arthroplasty: A review of pathogenetic mechanisms10.1016/j.actbio.2013.05.005 ↗
39. The role of fibroblasts and fibroblast-derived factors in periprosthetic osteolysis10.1002/art.22134 ↗
40. Oscar is a collagen receptor that costimulates osteoclastogenesis in dap12-deficient humans and mice10.1172/JCI45913 ↗
41. Histopathological analysis of peek wear particle effects on the synovial tissue of patients10.1155/2016/2198914 ↗
42. Metal wear particle characterization from metal on metal total hip replacements: Transmission electron microscopy study of periprosthetic tissues and isolated particles10.1002/(SICI)1097-4636(199810)42:1<103::AID-JBM13>3.0.CO;2-M ↗
43. Wear and biological activity of highly crosslinked polyethylene in the hip under low serum protein concentrations10.1243/09544119JEIM99 ↗
44. Clinical experience with metal-on-metal total joint replacements: Indications and results10.1243/095441105X69123 ↗
45. Dissemination of wear particles to the liver, spleen, and abdominal lymph nodes of patients with hip or knee replacement10.2106/00004623-200004000-00002 ↗
46. Toxicology-based cancer causation analysis of cocr-containing hip implants: A quantitative assessment of genotoxicity and tumorigenicity studies10.1002/jat.3039 ↗
47. Influence of particulate and dissociated metal-on-metal hip endoprosthesis wear on mesenchymal stromal cells in vivo and in vitro10.1016/j.biomaterials.2016.04.023 ↗
48. Role of particle size in phagocytosis of polymeric microspheres10.1007/s11095-008-9562-y ↗
49. Particle size affects the cellular response in macrophages10.1016/j.ejps.2010.09.006 ↗
50. Effects of metallic ion toxicity on human gingival fibroblasts morphology10.1016/S0142-9612(99)00044-7 ↗
51. Toxicity of chromium (vi) to two mussels and an amphipod in water-only exposures with or without a co-stressor of elevated temperature, zinc, or nitrate10.1007/s00244-017-0377-x ↗
52. Generation of hydroxyl radical by chromate in biologically relevant systems: Role of cr(v) complexes versus tetraperoxochromate(v)
53. Uptake of chromate in human red blood cells and isolated rat liver cells: The role of the anion carrier10.1039/an9952000931 ↗
54. Molecular and immune toxicity of cocr nanoparticles in mom hip arthroplasty10.1016/j.molmed.2011.12.002 ↗
55. International Agency for Research on Cancer (1999). Surgical Implants and Other Foreign Bodies, The International Agency for Research on Cancer (IARC).
56. Increased chromosome translocations and aneuploidy in peripheral blood lymphocytes of patients having revision arthroplasty of the hip10.1302/0301-620X.83B7.0831075 ↗
57. Metal-specific differences in levels of DNA damage caused by synovial fluid recovered at revision arthroplasty10.1302/0301-620X.87B10.16541 ↗
58. Chromosomal aberrations in the peripheral blood of patients with metal-on-metal hip bearings10.2106/JBJS.F.01435 ↗
59. Cancer incidence and causes of death among total hip replacement patients: A review based on nordic cohorts with a special emphasis on metal-on-metal bearings10.1243/095441105X63282 ↗
60. Osteolysis in a cementless, second generation metal-on-metal hip replacement10.1097/00003086-200105000-00020 ↗
61. Postmortem study of femoral osteolysis associated with metal-on-metal articulation in total hip replacement an analysis of nine cases10.2106/JBJS.I.00695 ↗
62. Modes of failure in metal-on-metal total hip arthroplasty10.1016/j.ocl.2014.11.001 ↗
63. Necrotic granulomatous pseudotumours in bilateral resurfacing hip arthoplasties: Evidence for a type iv immune response10.1007/s00428-008-0659-9 ↗
64. A 5-year survival analysis of 160 biomet magnum m2 metal-on-metal total hip prostheses10.5301/hipint.5000293 ↗
65. Histological features of pseudotumor-like tissues from metal-on-metal hips10.1007/s11999-010-1372-y ↗
66. Orthopaedic implant related metal toxicity in terms of human lymphocyte reactivity to metal-protein complexes produced from cobalt-base and titanium-base implant alloy degradation10.1023/A:1017979710992 ↗
67. Immune responses correlate with serum-metal in metal-on-metal hip arthroplasty10.1016/j.arth.2004.09.012 ↗
68. Tnf-alpha secretion and macrophage mortality induced by cobalt and chromium ions in vitro-qualitative analysis of apoptosis10.1016/S0142-9612(02)00351-4 ↗
69. Loosening and osteolysis associated with metal-on-metal bearings: A local effect of metal hypersensitivity?
70. Ceramic biomaterials: An introductory overview
71. Evolution of alumina-on-alumina implants-a review10.1097/00003086-200010000-00008 ↗
72. Alumina-alumina artificial hip joints. Part I: A histological analysis and characterisation of wear debris by laser capture microdissection of tissues retrieved at revision10.1016/S0142-9612(02)00047-9 ↗
73. Alumina-alumina artificial hip joints. Part II: Characterisation of the wear debris from in vitro hip joint simulations10.1016/S0142-9612(02)00048-0 ↗
74. The squeaking hip: A phenomenon of ceramic-on-ceramic total hip arthroplasty10.2106/JBJS.F.00970 ↗
75. Induction of macrophage apoptosis by ceramic and polyethylene particles in vitro10.1016/S0142-9612(98)00214-2 ↗
76. Characterisation of wear particles produced by metal on metal and ceramic on metal hip prostheses under standard and microseparation simulation
77. Biological reaction to alumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria10.1016/S0142-9612(03)00120-0 ↗
78. Christel, P.S. (1992). Biocompatibility of surgical-grade dense polycrystalline alumina. Clin. Orthop. Relat. Res., 10–18.10.1097/00003086-199209000-00003 ↗
79. Comparison of the cytotoxicity of clinically relevant cobalt-chromium and alumina ceramic wear particles in vitro10.1016/S0142-9612(02)00360-5 ↗
80. Ceramics in total hip replacement10.1097/01.blo.0000149996.91974.83 ↗
81. The in vitro genotoxicity of orthopaedic ceramic (Al2O3) and metal (cocr alloy) particles10.1016/j.mrgentox.2010.01.012 ↗
82. Differential apoptotic response of j774 macrophages to alumina and ultra-high-molecular-weight polyethylene particles10.1016/S0736-0266(01)00077-8 ↗
83. Effects of clinically relevant alumina ceramic wear particles on tnf-alpha production by human peripheral blood mononuclear phagocytes10.1016/S0142-9612(02)00510-0 ↗